FDA finalizes guidance on psychedelics, plans broader hearing

RegulatoryPositive

AI Analysis

Summary

The FDA finalized clinical guidance for psychedelic drug developers and scheduled a public hearing on future therapeutic use, signaling regulatory momentum in the psychedelics class.

Outcome Details

FDA finalized clinical guidance for psychedelic drug developers and scheduled public hearing

Importance:6/10

Sentiment:

0.60

psychedelicsFDA guidanceregulatory momentumclinical development

Related Companies

$FVNNU

Read the original article

Published by Endpoints News on July 13, 2026 6:52 PM

Read Original